Skinner, Jeff https://orcid.org/0000-0001-5697-0442
Kayentao, Kassoum
Ongoiba, Aissata
Healy, Sara A. https://orcid.org/0000-0003-3078-6094
Hu, Zonghui
Preston, Anne C.
Niangaly, Amadou
Schwabl, Philipp
Cisse, Hamidou https://orcid.org/0000-0003-0988-3332
Doumbo, Safiatou
Doumtabe, Didier
Traore, Abdrahamane
Li, Shanping
Peterson, Mary E.
Seilie, Annette M.
Chavtur, Chris
Staubus, Weston
Chang, Ming
Kelley, Katrina
Traore, Hamadi
Djiguiba, Adama
Keita, Mamadou
Ouattara, Adama
Doucoure, M’Bouye
Keita, Mohamed
Diarra, Djelika
Sylla, Mamadou
Diakite, Dramane
Konate, Mamadou
Traore, Siriman
Zéguimé, Amatigué
Dolo, Amagana
Neafsey, Daniel E. https://orcid.org/0000-0002-1665-9323
Murphy, Sean C. https://orcid.org/0000-0002-2048-0131
Traore, Boubacar
Seder, Robert A. https://orcid.org/0000-0003-3133-0849
Crompton, Peter D. https://orcid.org/0000-0001-5629-0412
Funding for this research was provided by:
Division of Intramural Research, National Institute of Allergy and Infectious Diseases
Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health
Bill and Melinda Gates Foundation (INV-052365, INV-061041)
Article History
Received: 4 October 2024
Accepted: 28 April 2025
First Online: 3 June 2025
Competing interests
: R.A.S. has filed patent PCT/US2018/017826 describing the CIS43 antibody. The other authors declare no competing interests.